ARTX / Arotech Corp. - تصريحات هيئة الأوراق المالية والبورصات، التقرير السنوي، بيان الوكيل

شركة اروتك
US ˙ NASDAQ ˙ US0426822039
هذا الرمز لم يعد نشطا

الإحصائيات الأساسية
LEI 529900Y6V47V8K481C47
CIK 916529
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Arotech Corp.
SEC Filings (Chronological Order)
توفر هذه الصفحة قائمة كاملة ومرتبة ترتيبًا زمنيًا لتصريحات هيئة الأوراق المالية والبورصات، باستثناء تصريحات الملكية التي نقدمها في مكان آخر.
December 30, 2019 15-12G

ARTX / Arotech Corp. 15-12G - - 15-12G

15-12G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 0-23336 AROTECH CORPORATION (Exact name of registrant as specified in

December 19, 2019 S-8 POS

ARTX / Arotech Corp. S-8 POS - - POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8

Post-Effective Amendment No. 1 to Form S-8 As filed with the Securities and Exchange Commission on December 19, 2019 Registration No. 333-19753 Registration No. 333-74197 Registration No. 333-59902 Registration No. 333-86728 Registration No. 333-124960 Registration No. 333-146752 Registration No. 333-160717 Registration No. 333-222465 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 POST-

December 19, 2019 POS AM

ARTX / Arotech Corp. POS AM - - POST-EFFECTIVE AMENDMENT NO.1 TO FORM S-3

Post-Effective Amendment No.1 to Form S-3 As filed with the Securities and Exchange Commission on December 19, 2019 Registration No. 333-195141 Registration No. 333-190808 Registration No. 333-153487 Registration No. 333-129713 Registration No. 333-128497 Registration No. 333-124959 Registration No. 333-112611 Registration No. 333-110729 Registration No. 333-110727 Registration No. 333-106420 Regi

December 19, 2019 POS AM

ARTX / Arotech Corp. POS AM - - POST-EFFECTIVE AMENDMENT NO.1 TO FORM S-3

Post-Effective Amendment No.1 to Form S-3 As filed with the Securities and Exchange Commission on December 19, 2019 Registration No. 333-195141 Registration No. 333-190808 Registration No. 333-153487 Registration No. 333-129713 Registration No. 333-128497 Registration No. 333-124959 Registration No. 333-112611 Registration No. 333-110729 Registration No. 333-110727 Registration No. 333-106420 Regi

December 19, 2019 POS AM

ARTX / Arotech Corp. POS AM - - POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3

Post-Effective Amendment No. 1 to Form S-3 As filed with the Securities and Exchange Commission on December 19, 2019 Registration No. 333-195141 Registration No. 333-190808 Registration No. 333-153487 Registration No. 333-129713 Registration No. 333-128497 Registration No. 333-124959 Registration No. 333-112611 Registration No. 333-110729 Registration No. 333-110727 Registration No. 333-106420 Reg

December 19, 2019 POS AM

ARTX / Arotech Corp. POS AM - - POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3

Post-Effective Amendment No. 1 to Form S-3 As filed with the Securities and Exchange Commission on December 19, 2019 Registration No. 333-195141 Registration No. 333-190808 Registration No. 333-153487 Registration No. 333-129713 Registration No. 333-128497 Registration No. 333-124959 Registration No. 333-112611 Registration No. 333-110729 Registration No. 333-110727 Registration No. 333-106420 Reg

December 19, 2019 POS AM

ARTX / Arotech Corp. POS AM - - POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3

Post-Effective Amendment No. 1 to Form S-3 As filed with the Securities and Exchange Commission on December 19, 2019 Registration No. 333-195141 Registration No. 333-190808 Registration No. 333-153487 Registration No. 333-129713 Registration No. 333-128497 Registration No. 333-124959 Registration No. 333-112611 Registration No. 333-110729 Registration No. 333-110727 Registration No. 333-106420 Reg

December 19, 2019 POS AM

ARTX / Arotech Corp. POS AM - - POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3

Post-Effective Amendment No. 1 to Form S-3 As filed with the Securities and Exchange Commission on December 19, 2019 Registration No. 333-195141 Registration No. 333-190808 Registration No. 333-153487 Registration No. 333-129713 Registration No. 333-128497 Registration No. 333-124959 Registration No. 333-112611 Registration No. 333-110729 Registration No. 333-110727 Registration No. 333-106420 Reg

December 19, 2019 S-8 POS

ARTX / Arotech Corp. S-8 POS - - POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8

Post-Effective Amendment No. 1 to Form S-8 As filed with the Securities and Exchange Commission on December 19, 2019 Registration No. 333-19753 Registration No. 333-74197 Registration No. 333-59902 Registration No. 333-86728 Registration No. 333-124960 Registration No. 333-146752 Registration No. 333-160717 Registration No. 333-222465 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 POST-

December 19, 2019 S-8 POS

ARTX / Arotech Corp. S-8 POS - - POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8

Post-Effective Amendment No. 1 to Form S-8 As filed with the Securities and Exchange Commission on December 19, 2019 Registration No. 333-19753 Registration No. 333-74197 Registration No. 333-59902 Registration No. 333-86728 Registration No. 333-124960 Registration No. 333-146752 Registration No. 333-160717 Registration No. 333-222465 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 POST-

December 19, 2019 EX-3.2

Amended and Restated Bylaws of Arotech Corporation.

EX-3.2 Exhibit 3.2 AMENDED AND RESTATED BYLAWS OF AROTECH CORPORATION (a Delaware corporation) Adopted: December 19, 2019 ARTICLE I Stockholders SECTION 1. Annual Meetings. The annual meeting of stockholders for the election of directors and for the transaction of such other business as may properly come before the meeting may be held each year at such date and time, within or without the State of

December 19, 2019 POS AM

ARTX / Arotech Corp. POS AM - - POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3

Post-Effective Amendment No. 1 to Form S-3 As filed with the Securities and Exchange Commission on December 19, 2019 Registration No. 333-195141 Registration No. 333-190808 Registration No. 333-153487 Registration No. 333-129713 Registration No. 333-128497 Registration No. 333-124959 Registration No. 333-112611 Registration No. 333-110729 Registration No. 333-110727 Registration No. 333-106420 Reg

December 19, 2019 POS AM

ARTX / Arotech Corp. POS AM - - POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3

Post-Effective Amendment No. 1 to Form S-3 As filed with the Securities and Exchange Commission on December 19, 2019 Registration No. 333-195141 Registration No. 333-190808 Registration No. 333-153487 Registration No. 333-129713 Registration No. 333-128497 Registration No. 333-124959 Registration No. 333-112611 Registration No. 333-110729 Registration No. 333-110727 Registration No. 333-106420 Reg

December 19, 2019 S-8 POS

ARTX / Arotech Corp. S-8 POS - - POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8

Post-Effective Amendment No. 1 to Form S-8 As filed with the Securities and Exchange Commission on December 19, 2019 Registration No. 333-19753 Registration No. 333-74197 Registration No. 333-59902 Registration No. 333-86728 Registration No. 333-124960 Registration No. 333-146752 Registration No. 333-160717 Registration No. 333-222465 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 POST-

December 19, 2019 S-8 POS

ARTX / Arotech Corp. S-8 POS - - POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8

Post-Effective Amendment No. 1 to Form S-8 As filed with the Securities and Exchange Commission on December 19, 2019 Registration No. 333-19753 Registration No. 333-74197 Registration No. 333-59902 Registration No. 333-86728 Registration No. 333-124960 Registration No. 333-146752 Registration No. 333-160717 Registration No. 333-222465 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 POST-

December 19, 2019 S-8 POS

ARTX / Arotech Corp. S-8 POS - - POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8

Post-Effective Amendment No. 1 to Form S-8 As filed with the Securities and Exchange Commission on December 19, 2019 Registration No. 333-19753 Registration No. 333-74197 Registration No. 333-59902 Registration No. 333-86728 Registration No. 333-124960 Registration No. 333-146752 Registration No. 333-160717 Registration No. 333-222465 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 POST-

December 19, 2019 POS AM

ARTX / Arotech Corp. POS AM - - POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3

Post-Effective Amendment No. 1 to Form S-3 As filed with the Securities and Exchange Commission on December 19, 2019 Registration No. 333-195141 Registration No. 333-190808 Registration No. 333-153487 Registration No. 333-129713 Registration No. 333-128497 Registration No. 333-124959 Registration No. 333-112611 Registration No. 333-110729 Registration No. 333-110727 Registration No. 333-106420 Reg

December 19, 2019 POS AM

ARTX / Arotech Corp. POS AM - - POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3

Post-Effective Amendment No. 1 to Form S-3 As filed with the Securities and Exchange Commission on December 19, 2019 Registration No. 333-195141 Registration No. 333-190808 Registration No. 333-153487 Registration No. 333-129713 Registration No. 333-128497 Registration No. 333-124959 Registration No. 333-112611 Registration No. 333-110729 Registration No. 333-110727 Registration No. 333-106420 Reg

December 19, 2019 POS AM

ARTX / Arotech Corp. POS AM - - POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3

Post-Effective Amendment No. 1 to Form S-3 As filed with the Securities and Exchange Commission on December 19, 2019 Registration No. 333-195141 Registration No. 333-190808 Registration No. 333-153487 Registration No. 333-129713 Registration No. 333-128497 Registration No. 333-124959 Registration No. 333-112611 Registration No. 333-110729 Registration No. 333-110727 Registration No. 333-106420 Reg

December 19, 2019 POS AM

ARTX / Arotech Corp. POS AM - - POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3

Post-Effective Amendment No. 1 to Form S-3 As filed with the Securities and Exchange Commission on December 19, 2019 Registration No. 333-195141 Registration No. 333-190808 Registration No. 333-153487 Registration No. 333-129713 Registration No. 333-128497 Registration No. 333-124959 Registration No. 333-112611 Registration No. 333-110729 Registration No. 333-110727 Registration No. 333-106420 Reg

December 19, 2019 POS AM

ARTX / Arotech Corp. POS AM - - POST-EFFECTIVE AMENDMENT NO. 2 TO FORM S-1

Post-Effective Amendment No. 2 to Form S-1 As filed with the Securities and Exchange Commission on December 19, 2019 Registration No. 333-133697 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Post-Effective Amendment No. 2 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 AROTECH CORPORATION (Exact name of registrant as specified in its charter) Delaware

December 19, 2019 POS AM

ARTX / Arotech Corp. POS AM - - POST-EFFECTIVE AMENDMENT NO.1 TO FORM S-3

Post-Effective Amendment No.1 to Form S-3 As filed with the Securities and Exchange Commission on December 19, 2019 Registration No. 333-195141 Registration No. 333-190808 Registration No. 333-153487 Registration No. 333-129713 Registration No. 333-128497 Registration No. 333-124959 Registration No. 333-112611 Registration No. 333-110729 Registration No. 333-110727 Registration No. 333-106420 Regi

December 19, 2019 S-8 POS

ARTX / Arotech Corp. S-8 POS - - POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8

Post-Effective Amendment No. 1 to Form S-8 As filed with the Securities and Exchange Commission on December 19, 2019 Registration No. 333-19753 Registration No. 333-74197 Registration No. 333-59902 Registration No. 333-86728 Registration No. 333-124960 Registration No. 333-146752 Registration No. 333-160717 Registration No. 333-222465 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 POST-

December 19, 2019 POS AM

ARTX / Arotech Corp. POS AM - - POST-EFFECTIVE AMENDMENT NO. 2 TO FORM S-3

Post-Effective Amendment No. 2 to Form S-3 As filed with the Securities and Exchange Commission on December 19, 2019 Registration No. 333-195141 Registration No. 333-190808 Registration No. 333-153487 Registration No. 333-129713 Registration No. 333-128497 Registration No. 333-124959 Registration No. 333-112611 Registration No. 333-110729 Registration No. 333-110727 Registration No. 333-106420 Reg

December 19, 2019 POS AM

ARTX / Arotech Corp. POS AM - - POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3

Post-Effective Amendment No. 1 to Form S-3 As filed with the Securities and Exchange Commission on December 19, 2019 Registration No. 333-195141 Registration No. 333-190808 Registration No. 333-153487 Registration No. 333-129713 Registration No. 333-128497 Registration No. 333-124959 Registration No. 333-112611 Registration No. 333-110729 Registration No. 333-110727 Registration No. 333-106420 Reg

December 19, 2019 EX-3.1

Second Amended and Restated Certificate of Incorporation of Arotech Corporation.

EX-3.1 2 d846016dex31.htm EX-3.1 Exhibit 3.1 SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF AROTECH CORPORATION ARTICLE ONE The name of the corporation is Arotech Corporation (hereinafter called the “Corporation”). ARTICLE TWO The address of the Corporation’s registered office is located at Corporation Service Company, 251 Little Falls Drive, Wilmington, New Castle County, Delaware 19

December 19, 2019 POS AM

ARTX / Arotech Corp. POS AM - - POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3

Post-Effective Amendment No. 1 to Form S-3 As filed with the Securities and Exchange Commission on December 19, 2019 Registration No. 333-195141 Registration No. 333-190808 Registration No. 333-153487 Registration No. 333-129713 Registration No. 333-128497 Registration No. 333-124959 Registration No. 333-112611 Registration No. 333-110729 Registration No. 333-110727 Registration No. 333-106420 Reg

December 19, 2019 POS AM

ARTX / Arotech Corp. POS AM - - POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3

Post-Effective Amendment No. 1 to Form S-3 As filed with the Securities and Exchange Commission on December 19, 2019 Registration No. 333-195141 Registration No. 333-190808 Registration No. 333-153487 Registration No. 333-129713 Registration No. 333-128497 Registration No. 333-124959 Registration No. 333-112611 Registration No. 333-110729 Registration No. 333-110727 Registration No. 333-106420 Reg

December 19, 2019 POS AM

ARTX / Arotech Corp. POS AM - - POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3

Post-Effective Amendment No. 1 to Form S-3 As filed with the Securities and Exchange Commission on December 19, 2019 Registration No. 333-195141 Registration No. 333-190808 Registration No. 333-153487 Registration No. 333-129713 Registration No. 333-128497 Registration No. 333-124959 Registration No. 333-112611 Registration No. 333-110729 Registration No. 333-110727 Registration No. 333-106420 Reg

December 19, 2019 POS AM

ARTX / Arotech Corp. POS AM - - POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3

Post-Effective Amendment No. 1 to Form S-3 As filed with the Securities and Exchange Commission on December 19, 2019 Registration No. 333-195141 Registration No. 333-190808 Registration No. 333-153487 Registration No. 333-129713 Registration No. 333-128497 Registration No. 333-124959 Registration No. 333-112611 Registration No. 333-110729 Registration No. 333-110727 Registration No. 333-106420 Reg

December 19, 2019 SC 13D/A

ARTX / Arotech Corp. / Kutler Jon B - AMENDMENT NO. 4 TO SCHEDULE 13D Activist Investment

Amendment No. 4 to Schedule 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 4)* Arotech Corporation (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class of Securities) 042682 20 3 (CUSIP Number) c/o Yaakov Har-Oz, Esq., Arotech Corporation, 1229 Oak Valley Drive, Ann Arbor, MI (734

December 19, 2019 S-8 POS

ARTX / Arotech Corp. S-8 POS - - POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8

Post-Effective Amendment No. 1 to Form S-8 As filed with the Securities and Exchange Commission on December 19, 2019 Registration No. 333-19753 Registration No. 333-74197 Registration No. 333-59902 Registration No. 333-86728 Registration No. 333-124960 Registration No. 333-146752 Registration No. 333-160717 Registration No. 333-222465 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 POST-

December 19, 2019 EX-99.1

Greenbriar Equity Group Completes Acquisition of Arotech Corporation

EX-99.1 Exhibit 99.1 Greenbriar Equity Group Completes Acquisition of Arotech Corporation ANN ARBOR, Mich. — December 19, 2019 — Arotech Corporation (NasdaqGM: ARTX) (“Arotech”) today announced the completion of its acquisition by an affiliate of Greenbriar Equity Group, L.P. (“Greenbriar”). The transaction, announced on September 22, 2019, was completed on December 19, 2019 following a majority s

December 19, 2019 8-K

Changes in Control of Registrant, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Material Modification to Rights of Security Holders, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets, Other Events

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 19, 2019 AROTECH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-23336 95-4302784 (State or other jurisdiction of incorporation) (Commission

December 17, 2019 8-K

Submission of Matters to a Vote of Security Holders

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 17, 2019 AROTECH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-23336 95-4302784 (State or other jurisdiction of incorporation) (Commission

December 5, 2019 DEFA14A

ARTX / Arotech Corp. DEFA14A - - DEFINITIVE ADDITIONAL MATERIALS

Definitive Additional Materials UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

November 22, 2019 DEFA14A

ARTX / Arotech Corp. DEFA14A - - DEFA14A

DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Pro

November 7, 2019 EX-10.1.5

Tenth amendment dated August 14, 2019 to Credit Agreement between JPMorgan Chase Bank, N.A. and Arotech Corporation and certain of Arotech Corporation’s subsidiaries dated March 11, 2016

TENTH AMENDMENT TO CREDIT AGREEMENT THIS TENTH AMENDMENT TO CREDIT AGREEMENT, dated as of August 14, 2019 (this “Amendment”), is among AROTECH CORPORATION (the “Borrower”), the other Loan Parties party to the Credit Agreement described below and JPMORGAN CHASE BANK, N.

November 7, 2019 10-Q

Quarterly Report - 10-Q

OMB APPROVAL OMB Number: 3235-0070 Expires: October 31, 2021 Estimated average burden hours per response 190.

November 6, 2019 EX-99.1

Earnings News

Earnings News Arotech Reports Third Quarter 2019 Results Ann Arbor, Michigan – November 6, 2019 – Arotech Corporation (NasdaqGM: ARTX) today announced financial results for the quarter and nine months ended September 30, 2019.

November 6, 2019 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

OMB APPROVAL OMB Number: 3235-0060 Expires: July 31, 2021 Estimated average burden hours per response 7.

November 4, 2019 DEFM14A

ARTX / Arotech Corp. DEFM14A - - DEFM14A

DEFM14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

October 23, 2019 PREM14A

ARTX / Arotech Corp. PREM14A - - PREM14A

PREM14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

September 23, 2019 DEFA14A

ARTX / Arotech Corp. DEFA14A - - DEFA14A

DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Pro

September 23, 2019 EX-2.1

Agreement and Plan of Merger dated September 22, 2019 between Arotech Corporation, Argonaut Intermediate, Inc. and Argonaut Merger Sub Inc.

EX-2.1 2 d806092dex21.htm EX-2.1 Exhibit 2.1 AGREEMENT AND PLAN OF MERGER by and among AROTECH CORPORATION, ARGONAUT INTERMEDIATE, INC. and ARGONAUT MERGER SUB, INC. Dated as of September 22, 2019 TABLE OF CONTENTS Page Article I. THE MERGER 2 Section 1.1 The Merger 2 Section 1.2 Closing 2 Section 1.3 Effective Time 2 Section 1.4 Organizational Documents of the Surviving Corporation 2 Section 1.5

September 23, 2019 EX-99.1

Arotech to be Acquired by Greenbriar for $3.00 Per Share in Cash Transaction Expected to Close in the 1st Quarter of 2020

EX-99.1 Exhibit 99.1 Arotech to be Acquired by Greenbriar for $3.00 Per Share in Cash Transaction Expected to Close in the 1st Quarter of 2020 ANN ARBOR, Mich. – September 23, 2019 – Arotech Corporation (NasdaqGM: ARTX) today announced that it has entered into a definitive agreement with an affiliate of Greenbriar Equity Group, L.P. (“Greenbriar”) under which the affiliate will acquire all outstan

September 23, 2019 EX-10.1

Voting Agreement, dated September 22, 2019, by and among Argonaut Intermediate, Inc., Arotech Corporation and the Holders party thereto.

EX-10.1 3 d806092dex101.htm EX-10.1 Exhibit 10.1 VOTING AGREEMENT THIS VOTING AGREEMENT (this “Agreement”) is made and entered into as of September 22, 2019, by and among Argonaut Intermediate, Inc., a Delaware corporation (“Parent”), Arotech Corporation, a Delaware corporation (the “Company”), and each of the undersigned stockholders of the Company (each, a “Holder”). RECITALS Pursuant to an Agre

September 23, 2019 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 22, 2019 AROTECH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-23336 95-4302784 (State or other jurisdiction of incorporation) (Comm

September 23, 2019 EX-99.1

Press release, dated September 23, 2019.

EX-99.1 Exhibit 99.1 Arotech to be Acquired by Greenbriar for $3.00 Per Share in Cash Transaction Expected to Close in the 1st Quarter of 2020 ANN ARBOR, Mich. – September 23, 2019 – Arotech Corporation (NasdaqGM: ARTX) today announced that it has entered into a definitive agreement with an affiliate of Greenbriar Equity Group, L.P. (“Greenbriar”) under which the affiliate will acquire all outstan

September 23, 2019 DEFA14A

ARTX / Arotech Corp. DEFA14A - - FORM 8-K

DEFA14A 1 d806092d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 22, 2019 AROTECH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-23336 95-4302784 (State or other jurisdictio

September 23, 2019 EX-2.1

Agreement and Plan of Merger, dated September 22, 2019, by and among Arotech Corporation, Argonaut Intermediate, Inc. and Argonaut Merger Sub, Inc.*

EX-2.1 Exhibit 2.1 AGREEMENT AND PLAN OF MERGER by and among AROTECH CORPORATION, ARGONAUT INTERMEDIATE, INC. and ARGONAUT MERGER SUB, INC. Dated as of September 22, 2019 TABLE OF CONTENTS Page Article I. THE MERGER 2 Section 1.1 The Merger 2 Section 1.2 Closing 2 Section 1.3 Effective Time 2 Section 1.4 Organizational Documents of the Surviving Corporation 2 Section 1.5 Directors 2 Section 1.6 Of

September 23, 2019 EX-10.1

Voting Agreement, dated September 22, 2019, by and among Argonaut Intermediate, Inc., Arotech Corporation and the Holders party thereto.

EX-10.1 3 d806092dex101.htm EX-10.1 Exhibit 10.1 VOTING AGREEMENT THIS VOTING AGREEMENT (this “Agreement”) is made and entered into as of September 22, 2019, by and among Argonaut Intermediate, Inc., a Delaware corporation (“Parent”), Arotech Corporation, a Delaware corporation (the “Company”), and each of the undersigned stockholders of the Company (each, a “Holder”). RECITALS Pursuant to an Agre

August 8, 2019 EX-10.1.4

Ninth amendment dated July 24, 2019 to Credit Agreement between JPMorgan Chase Bank, N.A. and Arotech Corporation and certain of Arotech Corporation’s subsidiaries dated March 11, 2016

EX-10.1.4 5 detroit-1506382x2xarotechn.htm EXHIBIT 10.1.4 NINTH AMENDMENT TO CREDIT AGREEMENT THIS NINTH AMENDMENT TO CREDIT AGREEMENT, dated as of July 24, 2019 (this “Amendment”), is among AROTECH CORPORATION (the “Borrower”), the other Loan Parties party to the Credit Agreement described below and JPMORGAN CHASE BANK, N.A. (the “Lender”). RECITAL The Borrower, the other Loan Parties and the Len

August 8, 2019 10-Q

ARTX / Arotech Corp. 10-Q - Quarterly Report - 10-Q

10-Q 1 arotech-063019x10q.htm 10-Q OMB APPROVAL OMB Number: 3235-0070 Expires: October 31, 2021 Estimated average burden hours per response 190.42 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED June 30, 2019. Commission file number: 0-23336 ARO

August 8, 2019 EX-10.1.1

Fifth amendment dated September 30, 2017 to Credit Agreement between JPMorgan Chase Bank, N.A. and Arotech Corporation and certain of Arotech Corporation’s subsidiaries dated March 11, 2016

FIFTH AMENDMENT TO CREDIT AGREEMENT THIS FIFTH AMENDMENT TO CREDIT AGREEMENT, effective as of September 30, 2017 (this “Amendment”), is among AROTECH CORPORATION (collectively, the “Borrower”), the other Loan Parties party to the Credit Agreement described below and JPMORGAN CHASE BANK, N.

August 8, 2019 EX-10.1.3

Seventh amendment dated July 19, 2018 to Credit Agreement between JPMorgan Chase Bank, N.A. and Arotech Corporation and certain of Arotech Corporation’s subsidiaries dated March 11, 2016

SEVENTH AMENDMENT TO CREDIT AGREEMENT THIS SEVENTH AMENDMENT TO CREDIT AGREEMENT, dated as of July 19, 2018 (this “Amendment”), is among AROTECH CORPORATION (collectively, the “Borrower”), the other Loan Parties party to the Credit Agreement described below and JPMORGAN CHASE BANK, N.

August 8, 2019 EX-10.1.2

Sixth amendment dated July 16, 2018 to Credit Agreement between JPMorgan Chase Bank, N.A. and Arotech Corporation and certain of Arotech Corporation’s subsidiaries dated March 11, 2016

SIXTH AMENDMENT TO CREDIT AGREEMENT THIS SIXTH AMENDMENT TO CREDIT AGREEMENT, dated as of July 16, 2018 (this “Amendment”), is among AROTECH CORPORATION (collectively, the “Borrower”), the other Loan Parties party to the Credit Agreement described below and JPMORGAN CHASE BANK, N.

August 7, 2019 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

8-K 1 a8k20190807q22019resultsdra.htm 8-K OMB APPROVAL OMB Number: 3235-0060 Expires: July 31, 2021 Estimated average burden hours per response 7.71 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 7, 2019 AROTECH CORPORATION

August 7, 2019 EX-99.1

Earnings News

Earnings News Arotech Reports Second Quarter 2019 Results Ann Arbor, Michigan – August 7, 2019 – Arotech Corporation (NasdaqGM: ARTX) today announced financial results for the quarter and six months ended June 30, 2019.

May 31, 2019 EX-1.01

Conflict Minerals Report as required by Items 1.01 and 1.02 of this Form

Exhibit 1.01 AROTECH CORPORATION CONFLICT MINERALS REPORT FOR THE YEAR ENDED DECEMBER 31, 2018 Arotech Corporation (“Arotech”) is submitting this report for the year ended December 31, 2018 in order to comply with Rule 13p-1 under the Securities Exchange Act of 1934 (the “Rule”). For the purpose of the required Reasonable Country of Origin Inquiry (“RCOI”), Arotech continued to receive supply chai

May 31, 2019 SD

ARTX / Arotech Corp. SD - - SD

OMB APPROVAL OMB Number: 3235-0697 Expires: June 30, 2019 Estimated average burden hours per response 480.

May 23, 2019 EX-99.1

INVESTOR PRESENTATION SPRING 2019 NASDAQ GM: ARTX WWW.AROTECH.COM SAFE HARBOR STATEMENT . This presentation contains forward-looking statements (within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securi

a2019irartxslides INVESTOR PRESENTATION SPRING 2019 NASDAQ GM: ARTX WWW.AROTECH.COM SAFE HARBOR STATEMENT . This presentation contains forward-looking statements (within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended) regarding Arotech Corporation (Arotech) and/or its subsidiaries, (collective ”the company”),

May 23, 2019 8-K

Regulation FD Disclosure, Financial Statements and Exhibits

8-K 1 a8-kxx2019x05x23fdmanageme.htm 8-K OMB APPROVAL OMB Number: 3235-0060 Expires: July 31, 2021 Estimated average burden hours per response 7.71 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 23, 2019 AROTECH CORPORATION (E

May 9, 2019 10-Q

ARTX / Arotech Corp. 10-Q Quarterly Report 10-Q

OMB APPROVAL OMB Number: 3235-0070 Expires: October 31, 2021 Estimated average burden hours per response 190.

May 8, 2019 EX-99.1

Earnings News

Earnings News Arotech Reports First Quarter 2019 Results Ann Arbor, Michigan – May 8, 2019 – Arotech Corporation (NasdaqGM: ARTX) today announced financial results for the quarter ended March 31, 2019.

May 8, 2019 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition, Submission of Matters to a Vote of Security Holders

OMB APPROVAL OMB Number: 3235-0060 Expires: July 31, 2021 Estimated average burden hours per response 7.

May 7, 2019 8-K/A

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

OMB APPROVAL OMB Number: 3235-0060 Expires: July 31, 2021 Estimated average burden hours per response 7.

May 7, 2019 EX-10.1

Eighth Amendment dated April 22, 2019 to Credit Agreement between JPMorgan Chase Bank, N.A. and Arotech Corporation and certain of Arotech Corporation’s subsidiaries dated March 11, 2016

Exhibit 10.1 EIGHTH AMENDMENT TO CREDIT AGREEMENT THIS EIGHTH AMENDMENT TO CREDIT AGREEMENT, dated as of April 22, 2019 (this “Amendment”), is among AROTECH CORPORATION (collectively, the “Borrower”), the other Loan Parties party to the Credit Agreement described below and JPMORGAN CHASE BANK, N.A. (the “Lender”). RECITAL The Borrower, the other Loan Parties and the Lender are parties to a Credit

April 25, 2019 EX-10.1

Eighth Amendment to Credit Agreement between the Registrant and JPMorgan Chase Bank, N.A. dated April 22, 2019

Exhibit 10.1 EIGHTH AMENDMENT TO CREDIT AGREEMENT THIS EIGHTH AMENDMENT TO CREDIT AGREEMENT, dated as of April 22, 2019 (this “Amendment”), is among AROTECH CORPORATION (collectively, the “Borrower”), the other Loan Parties party to the Credit Agreement described below and JPMORGAN CHASE BANK, N.A. (the “Lender”). RECITAL The Borrower, the other Loan Parties and the Lender are parties to a Credit

April 25, 2019 EX-10.2

Amended and Restated Employment Agreement between the Registrant and Corporation and Dean M. Krutty effective as of April 23, 2019

Exhibit 10.2 AMENDED AND RESTATED EMPLOYMENT AGREEMENT THIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT is signed on the 23rd day of April , 2019, effective as of the 23 day of April, 2019, by and between Arotech Corporation, a Delaware corporation with its offices at 1229 Oak Valley Drive, Ann Arbor, Michigan 48108 (the “Company”), and Dean M. Krutty, an individual residing at 8025 Trillium Lane, C

April 25, 2019 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

8-K 1 a8-kxx2019x04x22eighthamen.htm 8-K OMB APPROVAL OMB Number: 3235-0060 Expires: July 31, 2021 Estimated average burden hours per response 7.71 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8‑K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 22, 2019 AROTECH CORPORATION

April 19, 2019 8-K

Other Events

1 OMB Approval OMB Number: 3235-0060 Expires: July 31, 2021 Estimated average burden hours per response 7.

April 19, 2019 DEFA14A

ARTX / Arotech Corp. 8-K

1 OMB Approval OMB Number: 3235-0060 Expires: July 31, 2021 Estimated average burden hours per response 7.

March 22, 2019 DEFA14A

ARTX / Arotech Corp. DEFA14A

SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Definitive Proxy Statement ý Definitive Additional Materials o Soliciting Material under Rule 14a-12 AROTECH CORPORATION (Exact Name of Registrant as Specified in Charter) Payment of Filing Fee (Check the appropriate box): ý No fee required.

March 22, 2019 DEF 14A

ARTX / Arotech Corp. DEF 14A

SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ý Definitive Proxy Statement o Definitive Additional Materials o Soliciting Material under Rule 14a-12 AROTECH CORPORATION (Exact Name of Registrant as Specified in Charter) Payment of Filing Fee (Check the appropriate box): ý No fee required.

March 11, 2019 PRE 14A

ARTX / Arotech Corp. PRE 14A

***PRELIMINARY COPY*** SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: ý Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Definitive Proxy Statement o Definitive Additional Materials o Soliciting Material under Rule 14a-12 AROTECH CORPORATION (Exact Name of Registrant as Specified in Charter) Payment of Filing Fee (Check the appropriate box): ý No fee required.

March 7, 2019 10-K

ARTX / Arotech Corp. 10-K (Annual Report)

OMB APPROVAL OMB Number: 3235-0063 Expires: July 31, 2021 Estimated Average burden hours per response 2395.

March 6, 2019 8-K

Financial Statements and Exhibits, Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review, Results of Operations and Financial Condition

OMB APPROVAL OMB Number: 3235-0060 Expires: July 31, 2021 Estimated average burden hours per response 7.

March 6, 2019 EX-99.1

Earnings News

EX-99.1 2 artx2018q4earningspressrel.htm PRESS RELEASE DATED MARCH 6, 2019 Earnings News Arotech Reports Fourth Quarter and Full Year 2018 Results Ann Arbor, Michigan – March 6, 2019 – Arotech Corporation (NasdaqGM: ARTX) today announced financial results for the quarter and year ended December 31, 2018. Fourth Quarter and Full Year 2018 Financial Summary (2017 figures as restated; please see note

February 14, 2019 SC 13G/A

ARTX / Arotech Corp. / CANNELL CAPITAL LLC - SCHEDULE 13G/A Passive Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO §240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO §240.13d-2 (Amendment No.1) 1 AROTECH CORPORATION (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 042682203 (CUSIP Number) December 31, 2018 (Date

February 13, 2019 SC 13D/A

ARTX / Arotech Corp. / Arotech Corp - SC 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 3 )* Arotech Corporation (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class of Securities) 042682 20 3 (CUSIP Number) c/o Yaakov Har-Oz, Esq., Arotech Corporation, 1229 Oak Valley Drive, Ann Arbor, MI (734) 761-5836 (Name, Address and T

February 8, 2019 SC 13G

ARTX / Arotech Corp. / DIMENSIONAL FUND ADVISORS LP - SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* AROTECH CORP (Name of Issuer) Common Stock (Title of Class of Securities) 042682203 (CUSIP Number) December 31, 2018 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is

January 31, 2019 EX-10.1

Lease dated as of January 1, 2019 between UEC Properties, LLC and UEC Electronics, LLC

Exhibit 10.1 LEASE THIS LEASE (this “Lease”) made and entered into as of the 1st day of January, 2019 (the “Effective Date”) between UEC Properties, LLC, a South Carolina limited liability company (“Landlord”), and UEC Electronics, LLC, a South Carolina limited liability company (“Tenant”). WITNESSETH: In consideration of the mutual covenants and agreements contained herein, and other good and val

January 31, 2019 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

OMB APPROVAL OMB Number: 3235-0060 Expires: July 31, 2021 Estimated average burden hours per response 7.

December 27, 2018 EX-10.1

Employment Agreement between Arotech Corporation and Kelli L. Kellar effective as of January 1, 2019

arotech8k20181220kellarn AMENDED AND RESTATED EMPLOYMENT AGREEMENT THIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT is signed on the 10th day of December, 2018, effective as of the 1st day of January, 2019, by and between Arotech Corporation, a Delaware corporation with offices at 1229 Oak Valley Drive, Ann Arbor, Michigan 48108 (the “Company”), and Kelli L.

December 27, 2018 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Financial Statements and Exhibits

8-K 1 arotech8-kx2018x12x20xkel.htm 8-K OMB APPROVAL OMB Number: 3235-0060 Expires: July 31, 2021 Estimated average burden hours per response 7.71 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 20, 2018 AROTECH CORPORATIO

November 7, 2018 10-Q

ARTX / Arotech Corp. 10-Q (Quarterly Report)

OMB APPROVAL OMB Number: 3235-0070 Expires: July 31, 2021 Estimated average burden hours per response 190.

November 6, 2018 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

OMB APPROVAL OMB Number: 3235-0060 Expires: July 31. 2021 Estimated average burden hours per response 7.71 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 6, 2018 AROTECH CORPORATION (Exact name of registrant as specified

November 6, 2018 EX-99.1

Earnings News

Exhibit 99.1 Earnings News Arotech Reports Third Quarter 2018 Results Ann Arbor, Michigan – November 6, 2018 – Arotech Corporation (NasdaqGM: ARTX) today announced financial results for the three and nine months ended September 30, 2018. Third Quarter 2018 Financial Summary: Consolidated Nine months ended September 30, Three months ended September 30, U.S. $ in thousands, except per share data 201

August 8, 2018 10-Q

ARTX / Arotech Corp. 10-Q (Quarterly Report)

10-Q 1 arotech10q063018.htm 10-Q OMB APPROVAL OMB Number: 3235-0070 Expires: September 30, 2018 Estimated average burden hours per response 187.43 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED June 30, 2018. Commission file number: 0-23336 ARO

August 7, 2018 EX-99.1

Arotech Reports Second Quarter 2018 Results

Exhibit 99.1 Earnings News Arotech Reports Second Quarter 2018 Results Ann Arbor, Michigan – August 7, 2018 – Arotech Corporation (NasdaqGM: ARTX) today announced financial results for the three and six months ended June 30, 2018. Second Quarter 2018 Financial Summary: U.S. $ in thousands, except per share data Three months ended Three months ended June 30, 2018 June 30, 2017 March 31, 2018 GAAP M

August 7, 2018 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

8-K 1 arotech201808078k.htm FORM 8-K OMB APPROVAL OMB Number: 3235-0060 Expires: December 31. 2020 Estimated average burden hours per response 5.71 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 7, 2018 AROTECH CORPORATION

May 31, 2018 EX-1.01

Conflict Minerals Report as required by Items 1.01 and 1.02 of this Form

Exhibit 1.01 Arotech Corporation Conflict Minerals Report For The Year Ended December 31, 2017 Arotech Corporation (“Arotech”) is submitting this report for the year ended December 31, 2017 in order to comply with Rule 13p-1 under the Securities Exchange Act of 1934 (the “Rule”). For the purpose of the required Reasonable Country of Origin Inquiry (“RCOI”), Arotech continued to receive supply chai

May 31, 2018 SD

ARTX / Arotech Corp. SD

OMB APPROVAL OMB Number: 3235-0697 Expires: June 30, 2019 Estimated average burden hours per response 480.

May 24, 2018 EX-99.1

SPRING 2018nasdaq gm: artxwww.arotech.com Investor PRESENTATION Nasdaq: ARTX 2 SAFE HARBOR STATEMENT This presentation contains forward-looking statements (within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of

Exhibit 99.1 SPRING 2018nasdaq gm: artxwww.arotech.com Investor PRESENTATION Nasdaq: ARTX 2 SAFE HARBOR STATEMENT This presentation contains forward-looking statements (within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended) regarding Arotech Corporation (Arotech) and/or its subsidiaries, (collective ”the compa

May 24, 2018 8-K

Regulation FD Disclosure, Financial Statements and Exhibits

OMB APPROVAL OMB Number: 3235-0060 Expires: December 31, 2020 Estimated average burden hours per response 5.

May 10, 2018 10-Q

ARTX / Arotech Corp. 10-Q (Quarterly Report)

10-Q 1 arotech10q033118.htm 10-Q OMB APPROVAL OMB Number: 3235-0070 Expires: September 30, 2018 Estimated average burden hours per response 187.43 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED March 31, 2018. Commission file number: 0-23336 AR

May 9, 2018 EX-99.1

Arotech Reports First Quarter 2018 Results

Exhibit 99.1 Earnings News Arotech Reports First Quarter 2018 Results Ann Arbor, Michigan – May 9, 2018 – Arotech Corporation (NasdaqGM: ARTX) today announced financial results for the quarter ended March 31, 2018. First Quarter 2018 Financial Summary: U.S. $ in thousands, except per share data Three months ended March 31, 2018 2017 Three months ended December 31, 2017 GAAP Measures Revenue $ 27,2

May 9, 2018 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Results of Operations and Financial Condition, Submission of Matters to a Vote of Security Holders

8-K 1 arotech8k050918.htm 8-K OMB APPROVAL OMB Number: 3235-0060 Expires: May 31, 2018 Estimated average burden hours per response 5.71 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 8, 2018 AROTECH CORPORATION (Exact name of

March 26, 2018 DEFA14A

ARTX / Arotech Corp. DEFA14A

SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy Statement ☒ Definitive Additional Materials ☐ Soliciting Material under Rule 14a-12 AROTECH CORPORATION (Exact Name of Registrant as Specified in Charter) Payment of Filing Fee (Check the appropriate box): ☒ No fee required.

March 26, 2018 DEF 14A

ARTX / Arotech Corp. DEF 14A

SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy Statement ☐ Definitive Additional Materials ☐ Soliciting Material under Rule 14a-12 AROTECH CORPORATION (Exact Name of Registrant as Specified in Charter) Payment of Filing Fee (Check the appropriate box): ☒ No fee required.

March 15, 2018 10-K

ARTX / Arotech Corp. 10-K (Annual Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB APPROVAL OMB Number: 3235-0063 Expires: August 31, 2020 Estimated average burden hours per response 1,998.78 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2017. o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXC

March 15, 2018 EX-3.1

Amended and Restated Certificate of Incorporation

Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF ELECTRIC FUEL CORPORATION Electric Fuel Corporation, a corporation duly organized and existing under the laws of the State of Delaware, herby certifies as follows: 1. The name of this corporation is Electric Fuel Corporation. Electric Fuel Corporation was originally incorporated under the name of Luz Electric Fuel, Inc. The date of t

March 15, 2018 EX-10.8.4

Fourth amendment dated June 20, 2017 to Credit Agreement between JPMorgan Chase Bank, N.A. and Arotech Corporation and certain of Arotech Corporation’s subsidiaries dated March 11, 2016

Exhibit 10.8.4 EXECUTION VERSION FOURTH AMENDMENT TO CREDIT AGREEMENT THIS FOURTH AMENDMENT TO CREDIT AGREEMENT, dated as of June 20, 2017 (this “Amendment”), is among AROTECH CORPORATION (collectively, the “Borrower”), the other Loan Parties party to the Credit Agreement described below and JPMORGAN CHASE BANK, N.A. (the “Lender”). RECITAL The Borrower, the other Loan Parties and the Lender are p

March 15, 2018 EX-3.1.1

Amendment to Amended and Restated Certificate of Incorporation

Exhibit 3.1.1 CERTIFICATE OF AMENDMENT TO THE RESTATED CERTIFICATE OF INCORPORATION of ELECTRIC FUEL CORPORATION Electric Fuel Corporation, a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware, DOES HEREBY CERTIFY: FIRST: That in an unanimous written consent of the Board of Directors of this corporation a resolution was duly adopted setti

March 15, 2018 EX-10.13.1

Amendment dated August 30, 2017 to Employment Agreement between Arotech Corporation and Dean Krutty dated March 16, 2017 and effective as of January 1, 2017

Exhibit 10.13.1 Arotech Corporation Jon B. Kutler Chairman of the Board 1229 Oak Valley Drive Ann Arbor, Michigan 48108 Tel: (734) 761-5836 Fax: (734) 761-5368 http://www.arotech.com Nasdaq Global Market: ARTX August 30, 2017 VIA EMAIL [email protected] Mr. Dean Krutty 8025 Trillium Lane Canton, Michigan 48187 Re: Employment Agreement dated March 16, 2017 Dear Dean: In connection with your Emp

March 15, 2018 EX-10.8.3

Third amendment dated June 1, 2016 to Credit Agreement between JPMorgan Chase Bank, N.A. and Arotech Corporation and certain of Arotech Corporation’s subsidiaries dated March 11, 2016

Exhibit 10.8.3 EXECUTION VERSION THIRD AMENDMENT TO CREDIT AGREEMENT THIS THIRD AMENDMENT TO CREDIT AGREEMENT, dated as of June 1, 2017 (this “Amendment”), is among AROTECH CORPORATION (collectively, the “Borrower”), the other Loan Parties party to the Credit Agreement described below and JPMORGAN CHASE BANK, N.A. (the “Lender”). RECITAL The Borrower, the other Loan Parties and the Lender are part

March 15, 2018 EX-3.2

Amended and Restated By-Laws

EX-3.2 4 ex3-2.htm EX-3.2 Exhibit 3.2 AMENDED AND RESTATED BY-LAWS OF AROTECH CORPORATION Section 1. LAW, CERTIFICATE OF INCORPORATION AND BY-LAWS 1.1. These by-laws are subject to the certificate of incorporation of the corporation. In these by-laws, references to law, the certificate of incorporation and by-laws mean the law, the provisions of the certificate of incorporation and the by-laws as

March 15, 2018 EX-10.17

Purchase and Sale Agreement dated May 1, 2017 between FAAC Incorporated, and Oak Valley 1229, LLC

Exhibit 10.17 PURCHASE AND SALE AGREEMENT THIS PURCHASE AND SALE AGREEMENT (the “Agreement”) is made as of this 1st day of May, 2017 (the “Effective Date”) by and between FAAC INCORPORATED, a Michigan corporation (“Purchaser”) and OAK VALLEY 1229, LLC, a Michigan limited liability company (“Seller”). W I T N E S S E T H: WHEREAS, Seller is the owner of a parcel of land of approximately 2.46 acres

March 15, 2018 EX-10.8.2

Second amendment dated June 25, 2016 to Credit Agreement between JPMorgan Chase Bank, N.A. and Arotech Corporation and certain of Arotech Corporation’s subsidiaries dated March 11, 2016

Exhibit 10.8.2 SECOND AMENDMENT TO CREDIT AGREEMENT THIS SECOND AMENDMENT TO CREDIT AGREEMENT, dated as of June 25, 2016 (this “Amendment”), is among AROTECH CORPORATION (collectively, the “Borrower”), the other Loan Parties party to the Credit Agreement described below and JPMORGAN CHASE BANK, N.A. (the “Lender”). RECITAL The Borrower, the other Loan Parties and the Lender are parties to a Credit

March 15, 2018 EX-21.1

List of Subsidiaries of Arotech Corporation

Exhibit 21.1 Subsidiaries of the Registrant Name of Subsidiary Jurisdiction Owned By Percentage Ownership Epsilor-Electric Fuel Ltd. Israel Arotech Corporation 100.0% Arodelek Ltd. Israel Epsilor-Electric Fuel Ltd. 100.0% Electric Fuel Battery Corporation Delaware Arotech Corporation 100.0% FAAC Incorporated Michigan Arotech Corporation 100.0% UEC Electronics, LLC South Carolina Electric Fuel Batt

March 15, 2018 EX-10.8.1

First amendment dated June 3, 2016 to Credit Agreement between JPMorgan Chase Bank, N.A. and Arotech Corporation and certain of Arotech Corporation’s subsidiaries dated March 11, 2016

Exhibit 10.8.1 FIRST AMENDMENT TO CREDIT AGREEMENT THIS FIRST AMENDMENT TO CREDIT AGREEMENT, dated as of June 3, 2016 (this “Amendment”), is among AROTECH CORPORATION (collectively, the “Borrower”), the other Loan Parties party to the Credit Agreement described below and JPMORGAN CHASE BANK, N.A. (the “Lender”). RECITAL The Borrower, the other Loan Parties and the Lender are parties to a Credit Ag

March 14, 2018 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Results of Operations and Financial Condition

OMB APPROVAL OMB Number: 3235-0060 Expires: December 31, 2020 Estimated average burden hours per response 5.

March 14, 2018 EX-99.1

Earnings News

Exhibit 99.1 Earnings News Arotech Reports Fourth Quarter and Full Year 2017 Results Acting CEO Dean Krutty named President and CEO Ann Arbor, Michigan – March 14, 2018 – Arotech Corporation (NasdaqGM: ARTX) today announced financial results for the quarter and year ended December 31, 2017. Fourth Quarter and Full Year 2017 Financial Summary: U.S. $ in thousands, except per share data Twelve month

February 23, 2018 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

OMB APPROVAL OMB Number: 3235-0060 Expires: March 31, 2018 Estimated average burden hours per response 5.

February 23, 2018 EX-10.1

Lease dated as of December 31, 2017 between Epsilor-Electric Fuel Ltd. and Industrial Buildings Company, Ltd.

EX-10.1 2 ex10-1.htm EX-10.1 Exhibit 10.1 SUMMARY OF THE TERMS OF A LEASE AGREEMENT CONCERNING EPSILOR-EFL LTD’S FACILITY IN BEIT SHEMESH Building number: 271.28.01-03 Leased area in square meters (gross): 1,975 Date of the agreement: As of December 31, 2017 TERMS OF THE AGREEMENT between: Industrial Buildings Company, Ltd. 7 Totzeret Haaretz Street Tel Aviv Tel: 03-9070000 (hereinafter the “Compa

February 14, 2018 SC 13G/A

ARTX / Arotech Corp. / CANNELL CAPITAL LLC - SCHEDULE 13G Passive Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO §240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO §240.13d-2 (Amendment No.) 1 AROTECH CORPORATION (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 042682203 (CUSIP Number) December 31, 2017 (Date o

January 8, 2018 EX-99.1

Corporate News

Exhibit 99.1 Corporate News Arotech Hires New CFO Kelli Kellar to take over CFO duties from retiring CFO Tom Paup in April Ann Arbor, Michigan ? January 8, 2018 ? Arotech Corporation (NasdaqGM: ARTX) today announced that it has hired Kelli L. Kellar as Vice President ? Finance. Ms. Keller begins her employment with Arotech today, and starting April 1, 2018, Ms. Kellar will take over the role of ch

January 8, 2018 EX-10.1

Employment Agreement between Arotech Corporation and Kelli L. Kellar effective as of January 8, 2018

Exhibit 10.1 EMPLOYMENT AGREEMENT THIS AGREEMENT, effective as of the 8 th day of January, 2018, is entered into by and between Arotech Corporation, a Delaware corporation with offices at 1229 Oak Valley Drive, Ann Arbor, Michigan 48108 (the ?Company?), and Kelli L. Kellar, an individual residing at 1939 Cedar Hill Drive, Bloomfield Hills, Michigan 48301 (the ?Executive?). W I T N E S S E T H : WH

January 8, 2018 8-K

ARTX / Arotech Corp. 8-K (Current Report)

OMB APPROVAL OMB Number: 3235-0060 Expires: March 31, 2018 Estimated average burden hours per response 5.

January 8, 2018 EX-99.1

Arotech Corporation 2017 Non-Employee Director Equity Compensation Plan

Exhibit 99.1 AROTECH CORPORATION 2017 NON-EMPLOYEE DIRECTOR EQUITY COMPENSATION PLAN 1. Purposes of the Plan. The purposes of this Arotech Corporation 2017 Non-Employee Director Equity Compensation Plan are to attract qualified individuals for positions of responsibility as outside directors of the Company, and to provide incentives for qualified individuals to remain on the Board as outside direc

January 8, 2018 S-8

ARTX / Arotech Corp. S-8

S-8 1 arotech-s8010818.htm S-8 This Registration Statement shall become effective immediately upon filing pursuant to Securities Act Rule 462 As filed with the Securities and Exchange Commission on January 8, 2018 Registration No. 333- OMB APPROVAL OMB Number: 3235-0066 Expires: November 30, 2019 Estimated average burden hours per response 24.00 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Was

November 9, 2017 10-Q

ARTX / Arotech Corp. 10-Q (Quarterly Report)

OMB APPROVAL OMB Number: 3235-0070 Expires: September 30, 2018 Estimated average burden hours per response 187.

November 8, 2017 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

OMB APPROVAL OMB Number: 3235-0060 Expires: March 31, 2018 Estimated average burden hours per response 5.

November 8, 2017 EX-99.1

Earnings News

Exhibit 99.1 Earnings News Arotech Reports Third Quarter and Year-to-Date 2017 Results Ann Arbor, Michigan ? November 8, 2017 ? Arotech Corporation (NasdaqGM: ARTX) today announced financial results for the quarter and nine months ended September 30, 2017. Third Quarter 2017 Financial Summary: U.S. $ in thousands, except per share data Three months ended September 30, Three months ended June 30, 2

August 9, 2017 10-Q

ARTX / Arotech Corp. 10-Q (Quarterly Report)

OMB APPROVAL OMB Number: 3235-0070 Expires: September 30, 2018 Estimated average burden hours per response 187.

August 8, 2017 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

OMB APPROVAL OMB Number: 3235-0060 Expires: March 31, 2018 Estimated average burden hours per response 5.

August 8, 2017 EX-99.1

Earnings News

Exhibit 99.1 Earnings News Arotech Reports Second Quarter and Year-to-Date 2017 Results Ann Arbor, Michigan ? August 8, 2017 ? Arotech Corporation (NasdaqGM: ARTX) today announced financial results for the quarter and six months ended June 30, 2017. Second Quarter 2017 Financial Summary: U.S. $ in thousands, except per share data Three months ended June 30, Three months ended March 31, 2017 2017 2

May 30, 2017 SD

Arotech SD

OMB APPROVAL OMB Number: 3235-0697 Expires: June 30, 2019 Estimated average burden hours per response 480.

May 30, 2017 EX-1.01

Conflict Minerals Report as required by Items 1.01 and 1.02 of this Form

Exhibit 1.01 Arotech Corporation Conflict Minerals Report For The Year Ended December 31, 2016 Arotech Corporation (“Arotech”) is submitting this report for the year ended December 31, 2016 in order to comply with Rule 13p-1 under the Securities Exchange Act of 1934 (the “Rule”). For the purpose of the required Reasonable Country of Origin Inquiry (“RCOI”), Arotech continued to receive supply chai

May 24, 2017 EX-99.1

SPRING 2017nasdaq gm: artxwww.arotech.com Investor PRESENTATION Nasdaq: ARTX 2 SAFE HARBOR STATEMENT This presentation contains forward-looking statements (within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of

EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 SPRING 2017nasdaq gm: artxwww.arotech.com Investor PRESENTATION Nasdaq: ARTX 2 SAFE HARBOR STATEMENT This presentation contains forward-looking statements (within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended) regarding Arotech Corporation (Arotech) and/or its subsidi

May 24, 2017 8-K

Arotech 8-K (Current Report/Significant Event)

OMB APPROVAL OMB Number: 3235-0060 Expires: March 31, 2018 Estimated average burden hours per response 5.

May 9, 2017 10-Q

Arotech 10-Q (Quarterly Report)

0 OMB APPROVAL OMB Number: 3235-0070 Expires: September 30, 2018 Estimated average burden hours per response 187.

May 9, 2017 EX-99.1

Earnings News Arotech Reports First Quarter 2017 Results

Exhibit 99.1 Earnings News Arotech Reports First Quarter 2017 Results Ann Arbor, Michigan – May 8, 2017 – Arotech Corporation (NasdaqGM: ARTX) today announced financial results for the quarter ended March 31, 2017. First Quarter 2017 Financial Highlights: U.S. $ in thousands, except per share data Three months ended March 31, Three months ended December 31, 2016 2017 2016 GAAP Measures Revenue $ 2

May 9, 2017 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Results of Operations and Financial Condition, Submission of Matters to a Vote of Security Holders

OMB APPROVAL OMB Number: 3235-0060 Expires: March 31, 2018 Estimated average burden hours per response 5.

March 27, 2017 DEFA14A

Arotech DEFA 14A

arotech-defa14a033116.htm SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Definitive Proxy Statement x Definitive Additional Mater

March 27, 2017 DEF 14A

Arotech DEF 14A

SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy Statement ? Definitive Additional Materials ? Soliciting Material under Rule 14a-12 AROTECH CORPORATION (Exact Name of Registrant as Specified in Charter) Payment of Filing Fee (Check the appropriate box): ? No fee required.

March 16, 2017 10-K

Arotech 10-K (Annual Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB APPROVAL OMB Number: 3235-0063 Expires: March 31, 2017 Estimated average burden hours per response 2,003.78 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2016 . o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXC

March 16, 2017 EX-10.25

Employment Agreement between Arotech Corporation and Dean Krutty dated March 16, 2017 and effective as of January 1, 2017

Exhibit 10.25 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT is signed on the 16th day of March, 2017, effective as of the 1st day of January, 2017, by and between Arotech Corporation, a Delaware corporation with its offices at 1229 Oak Valley Drive, Ann Arbor, Michigan 48108 (the “Company”), and Dean M. Krutty, an individual residing at 8025 Trillium Lane, Canton, Michigan 48187 (the “Executive”)

March 15, 2017 EX-99.1

Earnings News

Exhibit 99.1 Earnings News Arotech Reports Fourth Quarter and Full Year 2016 results Ann Arbor, Michigan ? March 15, 2017 ? Arotech Corporation (NasdaqGM: ARTX) today announced financial results for its fourth quarter and twelve months ended December 31, 2016. Full-year 2016 Financial Highlights: ? Total revenues of $93.0 million in 2016 compared to $96.6 million in 2015, below 2016 guidance ? Net

March 15, 2017 8-K

Arotech 8-K (Current Report/Significant Event)

OMB APPROVAL OMB Number: 3235-0060 Expires: March 31, 2018 Estimated average burden hours per response 5.

January 30, 2017 EX-10.1

Amendment dated January 26, 2017 to Third Amended and Restated Employment Agreement, dated May 13, 2013 and effective as of May 1, 2013, between Arotech Corporation and Thomas J. Paup

Exhibit 10.1 Dean Krutty Executive Vice President, Operations ? North America and Acting CEO Arotech Corporation 1229 Oak Valley Drive Ann Arbor, Michigan 48108 Tel: (734) 761-5836 Fax: (734) 761-5368 http://www.arotech.com Nasdaq Global Market: ARTX Writer?s e-mail: [email protected] January 26, 2017 Mr. Thomas J. Paup c/o Arotech Corporation 1229 Oak Valley Road Ann Arbor, Michigan 48108 Re:

January 30, 2017 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

OMB APPROVAL OMB Number: 3235-0060 Expires: March 31, 2018 Estimated average burden hours per response 5.

January 3, 2017 EX-10.1

Separation and General Release Agreement between the Company and Epsilor, and Steven Esses, dated December 29, 2016

Exhibit 10.1 December 29, 2016 By E-mail Mr. Steven Esses Koresh 13 Efrat, Israel Dear Steven: As per our discussions, your employment with Arotech Corporation (? Arotech?) and Epsilor-Electric Fuel, Ltd. (? Epsilor?) (collectively, the ? Company?) will terminate by reason of your resignation effective as of the close of business on December 31, 2016. To ensure that all of the information related

January 3, 2017 8-K

Arotech 8-K (Current Report/Significant Event)

OMB APPROVAL OMB Number: 3235-0060 Expires: March 31, 2018 Estimated average burden hours per response 5.

January 3, 2017 EX-99.1

AROTECH AND CEO STEVEN ESSES ANNOUNCE EARLY CONTRACT TERMINATION Executive Vice President Dean Krutty named acting CEO

Exhibit 99.1 FOR IMMEDIATE RELEASE AROTECH AND CEO STEVEN ESSES ANNOUNCE EARLY CONTRACT TERMINATION Executive Vice President Dean Krutty named acting CEO Ann Arbor, Michigan ? January 3, 2017 ? Arotech Corporation (Nasdaq GM: ARTX) today announced the early termination of its employment agreement with Steven Esses, Arotech?s president and CEO and a member of the Board. Mr. Esses left the Company a

November 9, 2016 10-Q

Arotech 10-Q (Quarterly Report)

OMB APPROVAL OMB Number: 3235-0070 Expires: September 30, 2018 Estimated average burden hours per response 187.

November 8, 2016 EX-99.1

Earnings News

Exhibit 99.1 Earnings News FOR RELEASE AT 4PM ET NOVEMBER 8, 2016 Arotech Reports Third Quarter and Year-to-Date 2016 Results Diluted net income of $0.02 per share; continuing operations diluted net income of $0.06 per share Ann Arbor, Michigan ? November 8, 2016 ? Arotech Corporation (NasdaqGM: ARTX) today announced financial results for its third quarter and nine months ended September 30, 2016.

November 8, 2016 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

8-K 1 arotech8k110816.htm 8-K OMB APPROVAL OMB Number: 3235-0060 Expires: March 31, 2018 Estimated average burden hours per response 5.71 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 8, 2016 AROTECH CORPORATION (Exact n

October 12, 2016 SC 13D/A

ARTX / Arotech Corp. / Fields ephraim - AMEND #8 Activist Investment

Securities and exchange commission WASHINGTON, D.C. 20549 SCHEDULE 13D/A (Amendment No. 8) (Rule 13d-101) Under the Securities Exchange Act of 1934 Arotech Corporation (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class of Securities) 042682 20 3 (CUSIP Number) Ephraim Fields Echo Lake Capital 888 Seventh Avenue, 17th Floor New York, NY 10019 (212) 251-3381 (Name, Address and

October 7, 2016 SC 13D/A

ARTX / Arotech Corp. / Fields ephraim - SCHEDULE 13D AMENDMENT Activist Investment

SC 13D/A 1 fields13da7.htm SCHEDULE 13D AMENDMENT Securities and exchange commission WASHINGTON, D.C. 20549 SCHEDULE 13D/A (Amendment No. 7) (Rule 13d-101) Under the Securities Exchange Act of 1934 Arotech Corporation (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class of Securities) 042682 20 3 (CUSIP Number) Ephraim Fields Echo Lake Capital 888 Seventh Avenue, 17th Floor New

August 22, 2016 EX-10.1

Termination Agreement and Release between the Company and Epsilor, and Robert S. Ehrlich, dated August 22, 2016

Exhibit 10.1 Termination Agreement and Release Agreement (?Agreement?) entered into this 22nd day of August, 2016, by and be-tween Arotech Corporation, a Delaware corporation (?Arotech?) and Epsilor-Electric Fuel Ltd., an Israeli corporation (?Epsilor? and, together with Arotech, the ?Company?), and Robert S. Ehrlich, an individual residing at 21 Nahal Soreq Street, Beit Shemesh, Israel 9909129 (t

August 22, 2016 8-K

Arotech 8-K (Current Report/Significant Event)

OMB APPROVAL OMB Number: 3235-0060 Expires: March 31, 2018 Estimated average burden hours per response 5.

August 22, 2016 8-K

Arotech 8-K (Current Report/Significant Event)

OMB APPROVAL OMB Number: 3235-0060 Expires: March 31, 2018 Estimated average burden hours per response 5.

August 22, 2016 EX-99.1

Arotech to Discontinue Iron Flow Storage Project as of August 31, 2016; Seeks Buyer for Intellectual Property Chairman of Iron Flow project Robert S. Ehrlich agrees to early contract termination

Exhibit 99.1 Arotech to Discontinue Iron Flow Storage Project as of August 31, 2016; Seeks Buyer for Intellectual Property Chairman of Iron Flow project Robert S. Ehrlich agrees to early contract termination Ann Arbor, Michigan ? August 22, 2016 ? Arotech Corporation (Nasdaq GM: ARTX) today announced that as of August 31, 2016, it will discontinue all work on its Iron Flow Storage project. Arotech

August 22, 2016 EX-99.1

Arotech to Discontinue Iron Flow Storage Project as of August 31, 2016; Seeks Buyer for Intellectual Property Chairman of Iron Flow project Robert S. Ehrlich agrees to early contract termination

Exhibit 99.1 Arotech to Discontinue Iron Flow Storage Project as of August 31, 2016; Seeks Buyer for Intellectual Property Chairman of Iron Flow project Robert S. Ehrlich agrees to early contract termination Ann Arbor, Michigan ? August 22, 2016 ? Arotech Corporation (Nasdaq GM: ARTX) today announced that as of August 31, 2016, it will discontinue all work on its Iron Flow Storage project. Arotech

August 22, 2016 EX-10.1

Termination Agreement and Release between the Company and Epsilor, and Robert S. Ehrlich, dated August 22, 2016

Exhibit 10.1 Termination Agreement and Release Agreement (?Agreement?) entered into this 22nd day of August, 2016, by and be-tween Arotech Corporation, a Delaware corporation (?Arotech?) and Epsilor-Electric Fuel Ltd., an Israeli corporation (?Epsilor? and, together with Arotech, the ?Company?), and Robert S. Ehrlich, an individual residing at 21 Nahal Soreq Street, Beit Shemesh, Israel 9909129 (t

August 9, 2016 10-Q

Arotech 10-Q (Quarterly Report)

OMB APPROVAL OMB Number: 3235-0070 Expires: September 30, 2018 Estimated average burden hours per response 187.

August 8, 2016 EX-99.1

Corporate News

Exhibit 99.1 Corporate News FOR RELEASE AT 4PM ET AUGUST 8, 2016 Arotech Reports Second Quarter and Year-to-Date 2016 Results Ann Arbor, Michigan ? August 8, 2016 ? Arotech Corporation (NasdaqGM: ARTX) today announced financial results for its second quarter and six months ended June 30, 2016 and a more narrow range for its 2016 outlook. Second Quarter 2016 Financial and Business Highlights: ? Tot

August 8, 2016 8-K

Arotech 8-K (Current Report/Significant Event)

OMB APPROVAL OMB Number: 3235-0060 Expires: March 31, 2018 Estimated average burden hours per response 5.

June 6, 2016 SC 13D/A

ARTX / Arotech Corp. / Kutler Jon B - SC 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2)* Arotech Corporation (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class of Securities) 042682 20 3 (CUSIP Number) c/o Yaakov Har-Oz, Esq., Arotech Corporation, 1229 Oak Valley Drive, Ann Arbor, MI (734) 761-5836 (Name, Address and Te

May 31, 2016 EX-1.01

Conflict Minerals Report as required by Items 1.01 and 1.02 of this Form

Exhibit 1.01 Arotech Corporation Conflict Minerals Report For The Year Ended December 31, 2015 Arotech Corporation (?Arotech?) is submitting this report for the year ended December 31, 2015 in order to comply with Rule 13p-1 under the Securities Exchange Act of 1934 (the ?Rule?). For the purpose of the required Reasonable Country of Origin Inquiry (?RCOI?), Arotech continued to receive supply chai

May 31, 2016 SD

Arotech SD

OMB APPROVAL OMB Number: 3235-0697 Expires: June 30, 2016 Estimated average burden hours per response 480.

May 25, 2016 EX-99.1

Spring 2016 Management Presentation

Exhibit 99.1

May 25, 2016 8-K

Arotech 8-K (Current Report/Significant Event)

OMB APPROVAL OMB Number: 3235-0060 Expires: March 31, 2018 Estimated average burden hours per response 5.

May 10, 2016 10-Q

Arotech 10-Q (Quarterly Report)

arotech10q033116.htm 0 OMB APPROVAL OMB Number: 3235-0070 Expires: September 30, 2018 Estimated average burden hours per response 187.43 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED March 31, 2016. Commission file number: 0-23336 AROTECH CORP

May 10, 2016 EX-10.1

Amendment dated March 25, 2016 to Stock Purchase Agreement dated as of February 2, 2016 between Arotech Corporation and Admiralty Partners, Inc.

ex10-1.htm Exhibit 10.1 AMENDMENT NO. 2 TO STOCK PURCHASE AGREEMENT This AMENDMENT NO. 2 TO STOCK PURCHASE AGREEMENT (this “Amendment”) is made as of the 25th day of March, 2016, by and between Arotech Corporation, a Delaware corporation (the “Company”) and Admiralty Partners, Inc., a Delaware corporation (the “Investor”). WHEREAS, the parties hereto have entered into that certain Stock Purchase A

May 9, 2016 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Results of Operations and Financial Condition, Submission of Matters to a Vote of Security Holders

OMB APPROVAL OMB Number: 3235-0060 Expires: March 31, 2018 Estimated average burden hours per response 5.

May 9, 2016 EX-99.1

Corporate News

Exhibit 99.1 Corporate News Arotech Reports First Quarter Results Adjusted EBITDA of $1.5 Million Demonstrates Strong Operational Execution; Lead Independent Director Jon B. Kutler Elected Chairman of the Board of Directors Ann Arbor, Michigan – May 9, 2016 – Arotech Corporation (NasdaqGM: ARTX) today announced financial results for its first quarter ended March 31, 2016. First Quarter 2016 Financ

March 31, 2016 DEFA14A

Arotech DEFA 14A

arotech-defa14a033116.htm SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Definitive Proxy Statement x Definitive Additional Mater

March 30, 2016 DEF 14A

Arotech DEF 14A

arotech-def14a033016.htm SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Definitive Proxy Statement o Definitive Additional Materi

March 28, 2016 8-K

Arotech 8-K (Current Report/Significant Event)

arotech8k032516.htm OMB APPROVAL OMB Number: 3235-0060 Expires: March 31, 2018 Estimated average burden hours per response 5.71 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 25, 2016 AROTECH CORPORATION (Exact name of regis

March 28, 2016 EX-99.1

Arotech and Ephraim Fields of Echo Lake Capital Settle Proxy Contest

ex99-1.htm Exhibit 99.1 FOR IMMEDIATE RELEASE Arotech and Ephraim Fields of Echo Lake Capital Settle Proxy Contest Ann Arbor, Michigan – March 28, 2016 – Arotech Corporation (NasdaqGM: ARTX) and Mr. Ephraim Fields of Echo Lake Capital, Arotech’s largest stockholder, today announced an agreement (the “Agreement”) to settle their pending proxy contest in connection with Arotech’s 2016 Annual Meeting

March 28, 2016 EX-10.1

Settlement Agreement between Arotech Corporation and Ephraim Fields dated March 25, 2016

ex10-1.htm Exhibit 10.1 SETTLEMENT AGREEMENT This SETTLEMENT AGREEMENT (the “Agreement”) is made and entered into as of March 25, 2016, by and between Arotech Corporation, a Delaware corporation (“Arotech”), and Ephraim Fields (“Fields”). RECITALS WHEREAS, on December 10, 2015, Fields gave notice (the “Nomination Notice”) to Arotech of his intention to nominate director candidates at Arotech’s 201

March 28, 2016 EX-99.1

SETTLEMENT AGREEMENT

Exhibit 99.1 SETTLEMENT AGREEMENT This SETTLEMENT AGREEMENT (the “Agreement”) is made and entered into as of March 25, 2016, by and between Arotech Corporation, a Delaware corporation (“Arotech”), and Ephraim Fields (“Fields”). RECITALS WHEREAS, on December 10, 2015, Fields gave notice (the “Nomination Notice”) to Arotech of his intention to nominate director candidates at Arotech’s 2016 annual me

March 28, 2016 SC 13D/A

ARTX / Arotech Corp. / Fields ephraim - SCHEDULE 13D AMENDMENT Activist Investment

Securities and exchange commission WASHINGTON, D.C. 20549 SCHEDULE 13D/A (Amendment No. 6) (Rule 13d-101) Under the Securities Exchange Act of 1934 Arotech Corporation (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class of Securities) 042682 20 3 (CUSIP Number) Ephraim Fields Echo Lake Capital 888 Seventh Avenue, 17th Floor New York, NY 10019 (212) 251-3381 (Name, Address and

March 15, 2016 10-K

Arotech 10-K (Annual Report)

arotech10k123115.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB APPROVAL OMB Number: 3235-0063 Expires: March 31, 2018 Estimated average burden hours per response 1,998.78 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2015. o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) O

March 14, 2016 EX-10.1

Credit Agreement between JPMorgan Chase Bank, N.A. and Arotech Corporation and certain of Arotech Corporation’s subsidiaries dated March 11, 2016

ex10-1.htm Exhibit 10.1 Execution Copy CREDIT AGREEMENT dated as of March 11, 2016 among AROTECH CORPORATION and JPMORGAN CHASE BANK, N.A. TABLE OF CONTENTS Page ARTICLE I. Definitions 1 SECTION 1.01. Defined Terms 1 SECTION 1.02. Classification of Loans and Borrowings. 23 SECTION 1.03. Terms Generally. 24 SECTION 1.04. Accounting Terms; GAAP 24 SECTION 1.05. Pro Forma Adjustments for Acquisitions

March 14, 2016 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Results of Operations and Financial Condition

OMB APPROVAL OMB Number: 3235-0060 Expires: March 31, 2018 Estimated average burden hours per response 5.

March 14, 2016 EX-99.1

Corporate News

ex99-1.htm Exhibit 99.1 Corporate News Arotech Reports Profitable Fourth Quarter Fourth quarter net income increases 28% year-over-year Ann Arbor, Michigan ? March 14, 2016 ? Arotech Corporation (NasdaqGM: ARTX) today announced financial results for its fourth quarter and 12 months ended December 31, 2015. Fourth Quarter 2015 Financial and Business Highlights: ? Total revenues of $27.4 million ver

March 14, 2016 EX-10.3

Patent and Trademark Security Agreement between JPMorgan Chase Bank, N.A. and Arotech Corporation and certain of Arotech Corporation’s subsidiaries dated March 11, 2016

EX-10.3 4 ex10-3.htm EX-10.3 Exhibit 10.3 Execution Copy PATENT AND TRADEMARK SECURITY AGREEMENT THIS PATENT AND TRADEMARK SECURITY AGREEMENT (this “Agreement”) is entered into as of March 11, 2016 by and among Arotech Corporation, a Delaware corporation (the “Borrower”), FAAC Incorporated, a Michigan corporation (“FAAC”), Electric Fuel Battery Corp., a Delaware corporation (“EFBC”), UEC Electroni

March 14, 2016 EX-10.2

Pledge and Security Agreement between JPMorgan Chase Bank, N.A. and Arotech Corporation and certain of Arotech Corporation’s subsidiaries dated March 11, 2016

ex10-2.htm Exhibit 10.2 EXECUTION VERSION PLEDGE AND SECURITY AGREEMENT THIS PLEDGE AND SECURITY AGREEMENT (as it may be amended, restated, supplemented or otherwise modified from time to time, this “Security Agreement”) is entered into as of March 11, 2016 by and among Arotech Corporation, a Delaware corporation (the “Borrower”), FAAC Incorporated, a Michigan corporation (“FAAC”), Electric Fuel B

March 4, 2016 EX-99.1

Arotech Strengthens Corporate Governance by Adopting a Lead Independent Director Charter and Selecting Lead Director Board also votes to keep positions of Chairman and CEO separate going forward

ex99-1.htm Exhibit 99.1 Arotech Strengthens Corporate Governance by Adopting a Lead Independent Director Charter and Selecting Lead Director Board also votes to keep positions of Chairman and CEO separate going forward Ann Arbor, Michigan ? March 4, 2016 ? Arotech Corporation (Nasdaq GM: ARTX) announced today that its Board of Directors had voted yesterday to strengthen Arotech?s corporate governa

March 4, 2016 EX-99.2

AROTECH CORPORATION LEAD DIRECTOR CHARTER

ex99-2.htm Exhibit 99.2 AROTECH CORPORATION LEAD DIRECTOR CHARTER This Lead Director Charter (this ?Charter?) has been adopted by the Board of Directors (the ?Board?) in connection with its oversight of the management and business affairs of Arotech Corporation (the ?Company?). In circumstances where the Chairman of the Board (the ?Chairman?) is not independent (as determined by the Board in accor

March 4, 2016 8-K

Arotech 8-K (Current Report/Significant Event)

arotech8k030316.htm OMB APPROVAL OMB Number: 3235-0060 Expires: April 30, 2015 Estimated average burden hours per response 5.71 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 3, 2016 AROTECH CORPORATION (Exact name of regist

February 26, 2016 SC 13D/A

Arotech SC 13D/A (Activist Acquisition of More Than 5% of Shares)

arotech-sc13dakutler022516.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* Arotech Corporation (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class of Securities) 042682 20 3 (CUSIP Number) c/o Yaakov Har-Oz, Esq., Arotech Corporation, 1229 Oak Valley Drive, Ann Arbor, MI (734)

February 25, 2016 EX-10.1

Amendment dated February 23, 2016 to Stock Purchase Agreement dated as of February 2, 2016 between Arotech Corporation and Admiralty Partners, Inc.

ex10-1.htm Exhibit 10.1 EXECUTION VERSION AMENDMENT NO. 1 TO STOCK PURCHASE AGREEMENT This AMENDMENT NO. 1 TO STOCK PURCHASE AGREEMENT (this ?Amendment?) is made as of the 23rd day of February, 2016, by and between Arotech Corporation, a Delaware corporation (the ?Company?) and Admiralty Partners, Inc., a Delaware corporation (the ?Investor?). WHEREAS, the parties hereto have entered into that cer

February 25, 2016 EX-99.1

Arotech Director Seymour Jones Resigns for Health Reasons; Carol J. Battershell Appointed to His Seat As previously announced, Jon B. Kutler also joins Arotech’s Board

ex99-1.htm Exhibit 99.1 FOR IMMEDIATE RELEASE Arotech Director Seymour Jones Resigns for Health Reasons; Carol J. Battershell Appointed to His Seat As previously announced, Jon B. Kutler also joins Arotech?s Board Ann Arbor, Michigan ? February 25, 2016 ? Arotech Corporation (Nasdaq GM: ARTX) announced today that Prof. Seymour Jones, a director and Chairman of Arotech?s Audit Committee, has resign

February 25, 2016 EX-10.2

Voting Agreement dated as of February 23, 2016 between Robert S. Ehrlich, Steven Esses, and Admiralty Partners, Inc.

ex10-2.htm Exhibit 10.2 EXECUTION VERSION VOTING AGREEMENT This VOTING AGREEMENT (this ?Agreement?), is made as of the 23rd day of February, 2016 by and among Steven Esses, an individual residing at 13 Koresh Street, Efrat 9043500, Israel (?Esses?), Robert Ehrlich, an individual residing at 21/5 Nahal Soreq Street, Ramat Beit Shemesh 9909129, Israel (?Ehrlich?), and Admiralty Partners, Inc., a Del

February 25, 2016 8-K

Arotech 8-K (Current Report/Significant Event)

arotech8k022516.htm OMB APPROVAL OMB Number: 3235-0060 Expires: March 31, 2018 Estimated average burden hours per response 5.71 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 23, 2016 AROTECH CORPORATION (Exact name of re

February 23, 2016 EX-99.2

Ephraim Fields Criticizes Recent Arotech Financing

EXHIBIT 99.2 Ephraim Fields Criticizes Recent Arotech Financing - Criticizes selling 5.7% stake at below market prices to "friendly" shareholder - Criticizes failure to mention Consulting and Voting Agreements in press release - Questions Board entrenchment nature of the financing - Believes effective sale price significantly below $1.99 per share - Questions need to pay up to $375,000 in "consult

February 23, 2016 DFAN14A

SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ____)

SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.

February 23, 2016 EX-99.1

Common Stock

EXHIBIT 99.1 Common Stock Avg. Price Date Shares Purchased/(Sold) Per Share 2/16/2016 6,600 $2.21 2/12/2016 18,000 $2.27 2/11/2016 29,205 $2.27 2/10/2016 28,400 $2.27 2/10/2016 4,000 $2.28 2/9/2016 20,000 $2.27 2/9/2016 2,472 $2.28 2/8/2016 9,000 $2.25 2/5/2016 41,300 $2.33 2/5/2016 12,000 $2.31 1/11/2016 1,700 $2.27 In addition, on February 20, 2016, Ephraim Fields acquired 200,800 shares at $2.5

February 23, 2016 SC 13D/A

ARTX / Arotech Corp. / Fields ephraim Activist Investment

Securities and exchange commission WASHINGTON, D.C. 20549 SCHEDULE 13D/A (Amendment No. 5) (Rule 13d-101) Under the Securities Exchange Act of 1934 Arotech Corporation (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class of Securities) 042682 20 3 (CUSIP Number) Ephraim Fields Echo Lake Capital 888 Seventh Avenue, 17th Floor New York, NY 10019 (212) 251-3381 (Name, Address and

February 23, 2016 COVER

February 19, 2016

February 19, 2016 ATTORNEYS AT LAW 777 East Wisconsin Avenue, Suite 3800 Milwaukee, Wisconsin 53202-5306 414.

February 19, 2016 EX-99.1

AROTECH EXECUTIVE CHAIRMAN ROBERT S. EHRLICH DECIDES NOT TO SEEK REELECTION AS DIRECTOR; REAR ADMIRAL JAMES J. QUINN, USN (RET.) TO REPLACE HIM AS MANAGEMENT’S NOMINEE FOR ELECTION TO BOARD

EX-99.1 3 ex99-1.htm EX-99.1 Exhibit 99.1 AROTECH EXECUTIVE CHAIRMAN ROBERT S. EHRLICH DECIDES NOT TO SEEK REELECTION AS DIRECTOR; REAR ADMIRAL JAMES J. QUINN, USN (RET.) TO REPLACE HIM AS MANAGEMENT’S NOMINEE FOR ELECTION TO BOARD Ann Arbor, Michigan – February 19, 2016 /PRNewswire/ Arotech Corporation (Nasdaq GM: ARTX) announced today that its Executive Chairman of the Board, Robert S. Ehrlich,

February 19, 2016 8-K

Arotech 8-K (Current Report/Significant Event)

arotech8k021916.htm OMB APPROVAL OMB Number: 3235-0060 Expires: March 31, 2018 Estimated average burden hours per response 5.71 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 16, 2016 AROTECH CORPORATION (Exact name of re

February 19, 2016 EX-10.1

Fifth Amended and Restated Employment Agreement, dated February 16, 2016 and effective as of July 1, 2016, between Epsilor-Electric Fuel Ltd. and Arotech Corporation, and Steven Esses

ex10-1.htm Exhibit 10.1 FIFTH AMENDED AND RESTATED EMPLOYMENT AGREEMENT THIS AGREEMENT (?Agreement?) is signed on the 16th day of February, 2016, effective as of the 1st day of July, 2016, by and between Epsilor-Electric Fuel Ltd., an Israeli corporation (?Epsilor?), Arotech Corporation, a Delaware corporation (?Arotech? and, together with Epsilor, the ?Company?) and Mr. Steven Esses (the ?Executi

February 9, 2016 SC 13D

ARTX / Arotech Corp. / Kutler Jon B - SC 13D Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* Arotech Corporation (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class of Securities) 042682 20 3 (CUSIP Number) c/o Yaakov Har-Oz, Esq., Arotech Corporation, 1229 Oak Valley Drive, Ann Arbor, MI (734) 761-5836 (Name, Address and Tel

February 3, 2016 EX-99.1

Arotech Announces $3 Million Stock Investment by Admiralty Partners, Inc. Admiralty CEO Jon B. Kutler to Join Arotech’s Board of Directors

ex99-1.htm Exhibit 99.1 FOR IMMEDIATE RELEASE Arotech Announces $3 Million Stock Investment by Admiralty Partners, Inc. Admiralty CEO Jon B. Kutler to Join Arotech?s Board of Directors Ann Arbor, Michigan ? February 3, 2016 ? Arotech Corporation (Nasdaq GM: ARTX) announced today that it has signed a definitive agreement with internationally-recognized aerospace and defense investment firm Admiralt

February 3, 2016 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

arotech8k020216.htm OMB APPROVAL OMB Number: 3235-0060 Expires: March 31, 2018 Estimated average burden hours per response 5.71 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 2, 2016 AROTECH CORPORATION (Exact name of reg

February 3, 2016 EX-10.3

Consulting Agreement dated as of February 2, 2016 between the Company and Admiralty Partners, Inc.

ex10-3.htm Exhibit 10.3 Steven Esses President and Chief Executive Officer Arotech Corporation 1229 Oak Valley Drive Ann Arbor, Michigan 48108 Tel: (800) 281-0356 Fax: (734) 761-5368 http://www.arotech.com Nasdaq Global Market: ARTX Writer’s direct dial: +972-2-990-6618 Writer’s direct fax: +972-2-990-6623 Writer’s e-mail: [email protected] February 2, 2016 Admiralty Partners, Inc. 68-1052 Honoka’

February 3, 2016 EX-10.2

Registration Rights Agreement dated as of February 2, 2016 between Arotech Corporation and Admiralty Partners, Inc.

ex10-2.htm Exhibit 10.2 REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (?Agreement?) is made as of the 2nd day of February, 2016 by and between Arotech Corporation, a Delaware corporation (the ?Company?) and Admiralty Partners, Inc., a Delaware corporation (the ?Investor?). W I T N E S S E T H : WHEREAS, the Investor and the Company have entered into an Stock Purchase Agreement (

February 3, 2016 EX-10.1

Stock Purchase Agreement dated as of February 2, 2016 between Arotech Corporation and Admiralty Partners, Inc.

ex10-1.htm Exhibit 10.1 STOCK PURCHASE AGREEMENT THIS STOCK PURCHASE AGREEMENT (?Agreement?) is made as of the 2nd day of February, 2016 by and between Arotech Corporation, a Delaware corporation (the ?Company?) and Admiralty Partners, Inc., a Delaware corporation (the ?Investor?). W I T N E S S E T H : WHEREAS, the Company and the Investor are executing and delivering this Agreement in reliance u

January 11, 2016 EX-99.1

January 11, 2016

Exhibit 99.1 January 11, 2016 CERTIFIED MAIL RETURN RECEIPT REQUESTED AND OVERNIGHT DELIVERY Attention: Secretary of the Corporation, Yaakov Har-Oz Arotech Corporation 1229 Oak Valley Drive Ann Arbor, Michigan 48108 Re: Access to Stockholder List and Demand to Inspect Stockholder Records Pursuant to Section 220 of the Delaware General Corporation Law Ladies and Gentlemen: I, Ephraim Fields, hereby

January 11, 2016 SC 13D/A

ARTX / Arotech Corp. / Fields ephraim - AMENDMENT NO. 4 Activist Investment

SC 13D/A 1 fields13da4.htm AMENDMENT NO. 4 Securities and exchange commission WASHINGTON, D.C. 20549 SCHEDULE 13D/A (Amendment No. 4) (Rule 13d-101) Under the Securities Exchange Act of 1934 Arotech Corporation (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class of Securities) 042682 20 3 (CUSIP Number) Ephraim Fields Echo Lake Capital 888 Seventh Avenue, 17th Floor New York,

December 10, 2015 COVER

December 10, 2015

December 10, 2015 ATTORNEYS AT LAW 777 East Wisconsin Avenue, Suite 3800 Milwaukee, Wisconsin 53202-5306 414.

December 10, 2015 DFAN14A

SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ____)

SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.

December 10, 2015 SC 13D/A

ARTX / Arotech Corp. / Fields ephraim Activist Investment

Securities and exchange commission WASHINGTON, D.C. 20549 SCHEDULE 13D/A (Amendment No. 3) (Rule 13d-101) Under the Securities Exchange Act of 1934 Arotech Corporation (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class of Securities) 042682 20 3 (CUSIP Number) Ephraim Fields Echo Lake Capital 888 Seventh Avenue, 17th Floor New York, NY 10019 (212) 251-3381 (Name, Address and

November 10, 2015 NT 10-Q

Arotech NT 10-Q

arotech-nt10q093015.htm SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: October 31, 2018 Estimated average burden hours per response 2.50 SEC File Number 0-23336 CUSIP Number 042682 20 3 (Check one) o Form 10-K o Form 20-F o Form 11-K T Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: Sep

November 10, 2015 10-Q

OMB APPROVAL

OMB APPROVAL OMB Number: 3235-0070 Expires: September 30, 2018 Estimated average burden hours per response 187.

November 9, 2015 EX-99.1

Corporate News

ex99-1.htm Exhibit 99.1 Corporate News FOR RELEASE AT 4:05PM ET NOVEMBER 9, 2015 Arotech Reports Third Quarter and Year-To-Date 2015 Results Ann Arbor, Michigan ? November 9, 2015 ? Arotech Corporation (NasdaqGM: ARTX) today announced financial results for its quarter and nine months ended September 30, 2015. Third Quarter 2015 Financial and Business Highlights: ? Total revenues of $23.3 million v

November 9, 2015 8-K

Arotech 8-K (Current Report/Significant Event)

arotech8k110915.htm OMB APPROVAL OMB Number: 3235-0060 Expires: March 31, 2018 Estimated average burden hours per response 5.71 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 9, 2015 AROTECH CORPORATION (Exact name of reg

November 3, 2015 SC 13D/A

ARTX / Arotech Corp. / Fields ephraim - SCHEDULE 13D AMENDMENT Activist Investment

SC 13D/A 1 fieldssc13da2.htm SCHEDULE 13D AMENDMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 2)* AROTECH CORPORATION (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class of Securities) 042682 20 3 (CUSIP Number) Ephraim Fields Echo Lake Capital 888 Seventh Avenue, 17th Floor N

September 1, 2015 SC 13D/A

Arotech 3D/A (Activist Acquisition of More Than 5% of Shares)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* AROTECH CORPORATION (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class of Securities) 042682 20 3 (CUSIP Number) Ephraim Fields Echo Lake Capital 888 Seventh Avenue, 17th Floor New York, NY 10019 (212) 251-3381 Name, Address and T

August 11, 2015 10-Q

OMB APPROVAL OMB Number: 3235-0070 Expires: August 31, 2015 Estimated average burden hours per response 187.43 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

OMB APPROVAL OMB Number: 3235-0070 Expires: August 31, 2015 Estimated average burden hours per response 187.

August 10, 2015 EX-99.1

Corporate News

ex99-1.htm Exhibit 99.1 Corporate News FOR RELEASE AT 4PM ET AUGUST 10, 2015 Arotech Reports Second Quarter and Year-To-Date 2015 Results Training and Simulation Division achieves important milestones for pivotal programs ? Ann Arbor, Michigan ? August 10, 2015 ? Arotech Corporation (NasdaqGM: ARTX) today announced financial results for its quarter and six months ended June 30, 2015. Second Quarte

August 10, 2015 NT 10-Q

Arotech NT 10-Q

arotech-nt10q063015.htm SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: August 31, 2015 Estimated average burden hours per response 2.50 SEC File Number 0-23336 CUSIP Number 042682 20 3 (Check one) o Form 10-K o Form 20-F o Form 11-K T Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: June

August 10, 2015 8-K

Arotech 8-K (Current Report/Significant Event)

arotech8k081015.htm OMB APPROVAL OMB Number: 3235-0060 Expires: March 31, 2018 Estimated average burden hours per response 5.71 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 10, 2015 AROTECH CORPORATION (Exact name of regi

May 29, 2015 EX-1.01

Arotech Corporation

Unassociated Document Exhibit 1.01 Arotech Corporation Conflict Minerals Report For The Year Ended December 31, 2014 Arotech Corporation (?Arotech?) is submitting this report for the year ended December 31, 2014 in order to comply with Rule 13p-1 under the Securities Exchange Act of 1934 (the ?Rule?). For the purpose of the required Reasonable Country of Origin Inquiry (?RCOI?), Arotech continued

May 29, 2015 SD

Arotech SD

Unassociated Document OMB APPROVAL OMB Number: 3235-0697 Expires: May 31, 2016 Estimated average burden hours per response 480.

May 14, 2015 10-Q

OMB APPROVAL

0 OMB APPROVAL OMB Number: 3235-0070 Expires: May 31, 2015 Estimated average burden hours per response 187.

May 13, 2015 8-K

Arotech 8-K (Current Report/Significant Event)

arotech8k051215.htm OMB APPROVAL OMB Number:3235-0060 Expires:March 31, 2018 Estimated average burden hours per response 5.71 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 13, 2015 AROTECH CORPORATION (Exact name of registran

May 13, 2015 EX-99.1

May 2015 Management Presentation

ex99-1.htm Exhibit 99.1

May 12, 2015 8-K

Arotech 8-K (Current Report/Significant Event)

arotech8k051115.htm OMB APPROVAL OMB Number: 3235-0060 Expires: April 30, 2015 Estimated average burden hours per response 5.71 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 11, 2015 AROTECH CORPORATION (Exact name of registr

May 12, 2015 NT 10-Q

Arotech NT 10-Q

arotech-nt10q033115.htm SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: August 31, 2015 Estimated average burden hours per response 2.50 SEC File Number 0-23336 CUSIP Number 042682 20 3 (Check one) o Form 10-K o Form 20-F o Form 11-K T Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: Marc

May 12, 2015 EX-99.1

Corporate News

ex99-1.htm Exhibit 99.1 Corporate News FOR RELEASE AT 4PM ET MAY 11, 2015 Arotech Reports First Quarter Revenues of $24.2 Million; Adjusted EPS of $0.03 Reaffirms 2015 guidance for total revenue of $110 to $125 million, with adjusted earnings per share (Adjusted EPS) of $0.31 to $0.36; Relocation of facilities from Alabama to South Carolina Expected to Contribute to EPS Going Forward Ann Arbor, Mi

March 30, 2015 DEFA14A

Arotech DEFA14A

arotech-defa14a032515.htm SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Definitive Proxy Statement x Definitive Additional Mater

March 30, 2015 DEF 14A

Arotech DEF 14A

arotech-def14a032415.htm SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Definitive Proxy Statement o Definitive Additional Materi

March 23, 2015 SC 13D

ARTX / Arotech Corp. / Fields ephraim - SCHEDULE 13D Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* AROTECH CORPORATION (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class of Securities) 042682 20 3 (CUSIP Number) Ephraim Fields Echo Lake Capital 237 Park Ave – 9th Floor NY, NY 10017 (212) 251-3381 Name, Address and Telephone Number

March 20, 2015 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB APPROVAL OMB Number: 3235-0063 Expires: April 30, 2015 Estimated average burden hours per response 1,998.78 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2014 . o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXC

March 20, 2015 EX-21.1

List of Subsidiaries of the Registrant

Exhibit 21.1 Subsidiaries of the Registrant Name of Subsidiary Jurisdiction Percentage Ownership Epsilor-Electric Fuel Ltd. Israel 100.0% Electric Fuel Battery Corporation Delaware 100.0% FAAC Incorporated Michigan 100.0% UEC Electronics, LLC South Carolina 100.0%

March 20, 2015 EX-10.4

Lease dated October 31, 2014 between UEC Properties, LLC and UEC Electronics, LLC

Exhibit 10.4 LEASE THIS LEASE (this "Lease") made and entered into as of the 31st day of October, 2014 (the "Effective Date") between UEC Properties, LLC, a South Carolina limited liability company ("Landlord"), and UEC Electronics, LLC, a South Carolina limited liability company ("Tenant"). WITNESSETH: In consideration of the mutual covenants and agreements contained herein, and other good and va

March 19, 2015 EX-99.1

Spring 2015 Management Presentation

ex99-1.htm Exhibit 99.1

March 19, 2015 8-K

Arotech 8-K (Current Report/Significant Event)

arotech8k031915.htm OMB APPROVAL OMB Number:3235-0060 Expires:April 30, 2015 Estimated average burden hours per response 5.71 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 19, 2015 AROTECH CORPORATION (Exact name of registr

March 17, 2015 NT 10-K

Arotech NT 10-K

arotech-nt10k12314.htm SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: August 31, 2015 Estimated average burden hours per response 2.50 SEC File Number 0-23336 CUSIP Number 042682 20 3 (Check one) T Form 10-K o Form 20-F o Form 11-K o Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: Decem

March 16, 2015 EX-99.1

Corporate News

ex99-1.htm Exhibit 99.1 Corporate News Arotech Reports 2014 Record Annual Revenues of $103.5 Million; Full-Year Adjusted EBITDA of $10.0 Million Full-year Adjusted EBITDA exceeds high-end of 2014 guidance; annual and quarterly revenues increased 17% and 36%, respectively Company expects 2015 revenue of $110 to $125 million and adjusted EPS of $0.31 to $0.36 Ann Arbor, Michigan ? March 16, 2015 ? A

March 16, 2015 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

OMB APPROVAL OMB Number:3235-0060 Expires: April 30, 2015 Estimated average burden hours per response 5.

February 23, 2015 8-K

Other Events

OMB APPROVAL OMB Number:3235-0060 Expires:April 30, 2015 Estimated average burden hours per response 5.

February 12, 2015 SC 13D/A

Arotech Form SC 13D/A (Activist Acquisition of More Than 5% of Shares)

arotech-sc13daehrlich021215.htm OMB APPROVAL OMB Number: 3235-0145 Expires: February 28, 2009 Estimated average burden hours per response 14.5 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 5 )* Arotech Corporation (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class of Securities) 04

February 12, 2015 SC 13D/A

ARTX / Arotech Corp. / ESSES STEVEN D - SC 13D/A Activist Investment

OMB APPROVAL OMB Number: 3235-0145 Expires: February 28, 2009 Estimated average burden hours per response 14.

January 14, 2015 8-K

Regulation FD Disclosure, Financial Statements and Exhibits

OMB APPROVAL OMB Number:3235-0060 Expires:April 30, 2015 Estimated average burden hours per response 5.

January 14, 2015 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

OMB APPROVAL OMB Number: 3235-0060 Expires: April 30, 2015 Estimated average burden hours per response 5.

January 14, 2015 EX-99.1

Winter 2015 Management Presentation

Exhibit 99.1

January 14, 2015 EX-10.1

Amendment dated January 13, 2015 to Third Amended and Restated Employment Agreement, dated May 13, 2013 and effective as of May 1, 2013, between Arotech Corporation and Thomas J. Paup

Exhibit 10.1 Arotech Corporation 1229 Oak Valley Drive Ann Arbor, Michigan 48108 Tel: (734) 761-5836 Fax: (734) 761-5368 http://www.arotech.com Nasdaq Global Market: ARTX Writer’s direct dial: +972-2-990-6618 Writer’s direct fax: +972-2-990-6688 Writer’s e-mail: [email protected] Steven Esses President and Chief Executive Officer January 13, 2015 Mr. Thomas J. Paup c/o Arotech Corporation 1229 Oak

December 24, 2014 EX-10.1

Seventh Amended and Restated Employment Agreement, dated December 24, 2014 and effective as of January 1, 2015, between us, Epsilor-EFL and Robert S. Ehrlich

Exhibit 10.1 SEVENTH AMENDED AND RESTATED EMPLOYMENT AGREEMENT THIS AGREEMENT (“Agreement”) is signed on the 24th day of December, 2014, effective as of the 1st day of January, 2015, by and among Arotech Corporation, a Delaware corporation (“Arotech”), and Epsilor-Electric Fuel Ltd., an Israeli company (“Epsilor-EFL” and together with Arotech, the “Companies”), and Mr. Robert S. Ehrlich, Israel I.

December 24, 2014 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

OMB APPROVAL OMB Number:3235-0060 Expires:April 30, 2015 Estimated average burden hours per response 5.

November 14, 2014 EX-10.2

Second Amended and Restated Consulting Agreement, dated November 14, 2014 and effective as of October 1, 2014, between us and Sampen Corporation

Exhibit 10.2 Arotech Corporation 1229 Oak Valley Drive Ann Arbor, Michigan 48108 Tel: (800) 281-0356 Fax: (734) 761-5368 http://www.arotech.com Nasdaq National Market: ARTX Writer’s direct dial: +972-2-990-6612 Writer’s direct fax: +972-2-990-6688 Writer’s e-mail: [email protected] Robert S. Ehrlich Executive Chairman November 14, 2014 Sampen Corporation 1133 East 22nd Street Brooklyn, New York

November 14, 2014 10-Q

OMB APPROVAL

OMB APPROVAL OMB Number: 3235-0070 Expires: April 30, 2015 Estimated average burden hours per response 187.

November 14, 2014 EX-10.1

Fourth Amended and Restated Employment Agreement, dated November 14, 2014 and effective as of October 1, 2014, between us, Epsilor-EFL and Steven Esses

Exhibit 10.1 FOURTH AMENDED AND RESTATED EMPLOYMENT AGREEMENT THIS AGREEMENT (“Agreement”) is signed on the 14th day of November, 2014, effective as of the 1st day of October, 2014, by and between Epsilor-Electric Fuel Ltd., an Israeli corporation (“Epsilor”), Arotech Corporation, a Delaware corporation (“Arotech” and, together with Epsilor, the “Company”) and Mr. Steven Esses (the “Executive”). W

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista